UnknownNot Applicable

Endoscopic Frontal Sinus Surgery Draf III in Moderate to Severe Eosinophilic Chronic Rhinosinusitis With Polyps

Egypt50 participantsStarted 2021-01-01

Plain-language summary

The aim of this study is to evaluate the effect of the primary endoscopic frontal sinus surgery on the clinical outcome in patients having moderate to severe eosinophilic chronic rhinosinusitis with polyps with primary outcome measures in form of recurrence of polyp using endoscopic polyp score and Secondary outcome measures include Lund MacKay score, SNOT-22 and need for corticosteroid to control polyp postoperatively.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: • Patients with moderate or severe eosinophilic chronic rhinosinusitis with polyps who failed appropriate medical treatment in the form of antibiotic, systemic and local corticosteroid for 3 months . Exclusion Criteria: * Narrow anteroposterior diameter of frontal sinus ostium(1cm or less) * Patients showing less or highest degree of radiological complexity of surgery on studying the Computed Tomography. * Any contraindication for general anesthesia. * Patients below age of 18 years. * Incomplete follow up * previous sinus surgery

What they're measuring

Recurrence of polyp using endoscopic polyp score

Timeframe: One year postoperatively

Trial details

NCT IDNCT05979662

SponsorIbrahim Talal Elshamy

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-30

Contact for this trial

Ibrahim T Elshamy, MSc

+20 102 237 3920 hematalal93@gmail.com

View on ClinicalTrials.gov More Endoscopic Frontal Sinus Surgery trials